WinRho® SDF

Products



WinRho® SDF* [Rho (D) Immune Globulin (Human) for Injection]

WinRho® SDF, [Rho(D) Immune Globulin (Human) for Injection], Cangene’s flagship product, is sold worldwide and is available either as a liquid formulation or a freeze-dried powder.

WinRho® SDF is known as an anti-D product and is approved for two distinct indications.

WinRho® SDF was developed in 1968 by renowned pediatric researchers, Drs. Bruce Chown and John (Jack) Bowman. These physicians gained global recognition as pioneers for treating hemolytic disease of the newborn. In appreciation of their achievements, both physicians were made Officers of the Order of Canada.

If you are a U.S. resident or a U.S. healthcare professional, please visit www.winrho.com

*Product Information based on Canadian Product Monograph



The following information is available in Adobe Acrobat

Canadian Product Monographs:

English
French




WinRho® SDF Product Inquiries


Canada
Tel: 1-877-CANGENE (226-4363)
Email: customerservice@cangene.com  

United States
Tel: 1-800-4WinRho (494-6746)
Email: customerservice@cangene.com
www.cangenemedicalservices.com

International
Tel: 01 (204) 275-4178
Email: internationalsales@cangene.com

Cangene Medical Affairs

Tel: 1-800-768-2304
Email: medicalaffairs@cangene.com


Disclaimer This information is intended for residents of Canada only. Product names and prescribing information may vary in different jurisdistions.